Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBM Gel with rhBMP-2 vs DBM Gel in TLIF for Lumbar Disc Disease (KCT0005412)
KCT0005412Phase 3Completed
- Sponsor
- Korea Health Industry Development Institute
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dibotermin alfa in lumbar disc disease, sponsored by Korea Health Industry Development Institute. Started Mar 2014; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
lumbar disc disease
Beyond the preview
Go deeper on KCT0005412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005412.